Showing 341 - 360 results of 106,048 for search '(( 50 ((mean decrease) OR (we decrease)) ) OR ( 5 ((mg decrease) OR (a decrease)) ))', query time: 0.96s Refine Results
  1. 341
  2. 342
  3. 343
  4. 344
  5. 345
  6. 346
  7. 347
  8. 348
  9. 349
  10. 350

    Receptor specific silencing decreases NGF induced apoptosis. by Alessandra Micera (294762)

    Published 2013
    “…A 37.5%-decrease (*) and a 50%-decrease (**) of apoptotic signal were detected respectively in p75<sup>NTR</sup>-siRNA and p75<sup>NTR</sup>/trkA<sup>NGFR</sup>-siRNA (p<.05).…”
  11. 351
  12. 352
  13. 353
  14. 354
  15. 355

    Low concentrations of siRNA TMPRSS2-ERG III and IV impair TMPRSS2-ERG oncogene and oncoprotein levels but not cell viability. by Giorgia Urbinati (554921)

    Published 2015
    “…<p>VCaP cells were transfected for 72h from 2.5 nM to 50 nM with siRNA TMPRSS2-ERG III, siRNA TMPRSS2-ERG IV or siRNA Control. …”
  16. 356
  17. 357
  18. 358

    Vectorized siRNA TMPRSS2-ERG IV-SQ impaired tumour growth and restored differentiation <i>in vivo</i>. by Giorgia Urbinati (554921)

    Published 2015
    “…<p><b>a.</b> SCID mice (n = 5/group) bearing VCaP tumour xenografts were injected intravenously either with NaCl 0.9%, non-vectorized siRNA TMPRSS2-ERG IV, NPs siRNA control-SQ or NPs siRNA TMPRSS2-ERG IV-SQ twice per week during 6 weeks (1.8 mg/kg/mouse cumulative dose). …”
  19. 359

    2-NBDG<sub>60</sub> is sensitive to a decrease in blood glucose levels. by Narasimhan Rajaram (474255)

    Published 2015
    “…<p><b>A</b>. Representative 2-NBDG kinetic profiles for 3 different fasting groups of mice after injection of a 6 mM (2mg/ml) dose via the tail-vein. …”
  20. 360